Although these genes are found to be overexpressed in several malignant tumours, including gastric and colon cancers, it remains unclear whether the products of FGF9, FLT1 and KLF5 are overexpressed in colorectal intramucosal adenocarcinoma [26–28, 31]. This evidence concerns the gene FGF9 and cancer.